Researchers has significantly boosted this development of a novel solution for ATTR-CM, employing the investigational drug. Early trial results indicates potential benefits for those diagnosed with this severe https://bridgebio042170.diowebhost.com/97353464/bridgebio-progresses-attr-cm-therapy-with-the-drug